Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Plain language summary:
“Age, sex, smoking status and other common factors may predict which patients with axial spondyloarthritis achieve inactive disease when treated with TNF inhibitors”
This is a plain language summary of the scientific publication from EuroSpA: “Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors – Data from the EuroSpA collaboration” by Ørnbjerg, Linde, Georgiadis et. al.
You can read the original article published in Seminars in Arthritis and Rheumatism in 2022 here: https://www.sciencedirect.com/science/article/pii/S0049017222001329?via%3Dihub
